Med24
metabolic-therapy 18. 10. 2026 • 2 min read • Journal of gastroenterology and hepatology (PubMed)

Impact of Physical Activity on Cardiovascular Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease.

AIM: We investigated whether accelerometer-assessed moderate-to-vigorous physical activity (MVPA) is associated with cardiovascular mortality among individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) in the United States. METHODS: We performed a longitudinal analysis using the 2003-2006...

Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

This research investigated the relationship between physical activity and cardiovascular outcomes in adults with metabolic dysfunction-associated steatotic liver disease (MASLD) in the United States. The study utilized data from the 2003-2006 US National Health and Nutrition Examination Survey, tracking mortality through December 2019. HSI was primarily defined using the Hepatic Steatosis Index (HSI), with sensitivity analyses employing the US Fatty Liver Index (USFLI).

Sponsored content

Key Clinical Findings

A total of 2785 individuals with HSI-defined MASLD were included in the analysis, experiencing 584 deaths, including 198 cardiovascular deaths over a median follow-up of 14.7 years. Results indicated a non-linear association between increasing moderate-to-vigorous physical activity (MVPA) and reduced all-cause mortality. Specifically, an increase of 10 minutes in MVPA was associated with a hazard ratio of 0.80 (95% CI: 0.71-0.91, P < 0.001). Similarly, higher MVPA was associated with a lower risk of cardiovascular mortality in MASLD, with a hazard ratio of 0.72 (95% CI: 0.53-0.99, P = 0.009). Total physical activity showed a weaker association with mortality compared to MVPA. Increased sedentary behavior did not impact mortality in the MASLD group.

Original Scientific Source
Journal of gastroenterology and hepatology (PubMed)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.
metabolic-therapy

Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.

Insulin resistance is an important metabolic derangement contributing to the pathogenesis of type 2 diabetes, obesity, metabolic syndrome, and other chronic diseases, underlining the requirement for techniques that enable in vivo analysis of tissue-specific glucose metabolism. 18F-fluorodeoxyglucose positron emission...

10. 11. 2026 Read article →
Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.
metabolic-therapy

Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.

BACKGROUND: Although body mass index (BMI) is widely used to assess obesity-related health risks, it may fail to detect individuals with normal weight who present with significant cardiometabolic abnormalities. This phenotype, often overlooked in clinical practice, is associated with increased risk of cardiovascular...

30. 10. 2026 Read article →
Advertisement